May 26, 2026 by Adam LevyMeet the Company Taking on SpaceX and Tesla -- It Could Be Worth More Than Both Combined by 2027Robotaxis and satellite internet are side projects to this undervalued AI giant.
May 25, 2026 by Reuben Gregg BrewerGlobal Oil Inventories Are at an 11-Year Low and Getting Worse. Here's Where Investors Should Look Now.Oil markets are in disarray, and there's no easy fix, which is why you might want to sidestep commodity risk.
May 25, 2026 by Prosper Junior BakinyBetter Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics?Are there significant gains ahead for one (or both) of these innovative biotechs?
May 26, 2026 by Adam LevyMeet the Company Taking on SpaceX and Tesla -- It Could Be Worth More Than Both Combined by 2027Robotaxis and satellite internet are side projects to this undervalued AI giant.
May 26, 2026 by Jack DelaneyTop 3 Energy Dividend Stocks for Reliable Income in 2026These three stocks allow you to generate reliable income.
May 26, 2026 by Alex CarchidiIs XRP Still Worth Buying at Today's Price?Focusing on price is a mistake with this coin.
May 25, 2026 by Manali Pradhan, CFABefore the Next Nvidia-Style Run, Here Are 3 AI Stocks Worth WatchingThe next AI winners may come from the companies that help move data in AI data centers.
May 25, 2026 by James Halley2 Building Materials Stocks That Are Quietly Becoming Some of the Market's Best OpportunitiesArmstrong World Industries and Carlisle Companies are outpacing other building materials stocks.
May 25, 2026 by Robert IzquierdoIs Vail Resorts Stock a Buy After Oasis Management Added Over 237,000 Shares to Its Position?Vail Resorts operates 37 mountain destinations, combining lift ticket sales, hospitality, and real estate across North America.
May 25, 2026 by James HalleyIs Green Thumb Becoming the "Procter & Gamble of Cannabis"?Cannabis company Green Thumb is younger and in a different sector than consumer staples giant Procter & Gamble, but it's succeeding with similar methods.
May 25, 2026 by Micah ZimmermanThe 1 AI Stock I'd Put in a Time Capsule and Open in 2036A speculative but compelling AI biotech investment can be built around Absci and its attempt to rewire drug discovery itself.
May 25, 2026 by Lyle DalyThis AI Stock Has Been Called Overvalued for 3 Years. The Bears Keep Losing.The critics have missed out on substantial returns.
May 25, 2026 by Robert IzquierdoBooking Holdings vs. Airbnb: What Their Revenue Trends Tell InvestorsQuarterly filings reveal how each platform navigates travel’s off-peak slumps and peak surges, with margins and partnerships shaping the competitive landscape.
May 25, 2026 by Reuben Gregg BrewerGlobal Oil Inventories Are at an 11-Year Low and Getting Worse. Here's Where Investors Should Look Now.Oil markets are in disarray, and there's no easy fix, which is why you might want to sidestep commodity risk.
May 25, 2026 by Selena MaranjianThis Social Security Surprise Could Upend Your Retirement BudgetSocial Security isn't exactly running out of money -- but your benefits are at risk.
May 25, 2026 by Robert IzquierdoIradimed’s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors?This medical device specialist, known for MRI-compatible equipment, reported a notable insider sale amid strong one-year share gains.
May 25, 2026 by Prosper Junior BakinyBetter Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics?Are there significant gains ahead for one (or both) of these innovative biotechs?
May 25, 2026 by Dominic BasultoShould You Forget Ethereum and Buy This Cryptocurrency Instead?Ethereum may still be the market leader, but this upstart rival is now growing much more quickly.
May 25, 2026 by Reuben Gregg BrewerJPMorgan Chase Says It Is Comfortable With $50 Billion in Private Credit Exposure. Should Investors Be?JPMorgan is focused on the big picture, and you should probably do the same if you own the stock.
May 25, 2026 by Thomas NielDon't Buy Viking Therapeutics Stock Until You Read ThisIt may be too late for Viking to take on the "dark horse" role in the GLP-1 wars.
May 25, 2026 by David Jagielski, CPAIs Nvidia the Most Underrated Dividend Growth Stock to Own?Nvidia's dividend is going up by 2,400%.
May 25, 2026 by Prosper Junior BakinyRecursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now?The stock looks cheap, but appearances can be deceiving.
May 25, 2026 by David Jagielski, CPAWhy SoundHound's Oasys Platform Could Be a Game Changer for Its BusinessThe company's new platform uses AI to build AI.
